Study on CeraVe skincare for acne
Part of Skin clinical trials.
This study looks at how well CeraVe skincare products work for people with acne. It is for Chinese teens and adults aged 13 and older who have mild to severe acne and have started acne treatment in the last 3 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are Chinese, at least 13 years old, and in good general health.
- You have mild, moderate, or severe acne as judged by a skin doctor.
- You started acne medicine (like creams or pills) within the last 3 months.
- If you have moderate or severe acne, you must have been using acne medicine for at least 2 weeks (4 weeks for pills) before joining.
- You are not pregnant, breastfeeding, or planning a pregnancy during the study.
- You have not had laser, chemical peels, or other cosmetic procedures in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a cosmetic product alongside a standard prescription acne treatment for 12 weeks, then a maintenance phase to see if the product helps improve acne and skin appearance.
This trial tests skincare products designed for people with sensitive skin who have mild to moderate acne. The goal is to see if they safely and effectively reduce acne without irritating sensitive skin.
This study tests a new acne treatment in adults. It aims to see if the treatment works well and is safe for people with acne.
This study is for people aged 18 to 25 with mild, moderate, or severe facial acne, and also for healthy volunteers without acne. Researchers want to learn more about acne by taking skin samples and blood samples, and no experimental treatments are given.
This trial tests whether a cream called Social Renew can improve acne symptoms and help skin heal in healthy adults. If you have visible facial acne and are between 18 and 65, you may qualify.
This early-stage study tests a new drug called TVB-3567, which may help treat acne. It checks the drug's safety and how the body processes it, first in healthy people and then in people with moderate to severe acne.
Hear when a new Acne trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.